Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitis-Reference-Cited by-同舟云学术

Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitis

Published:2019-06-26 Issue:12 Volume:58 Page:2333-2335
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Houben Eline¹²,Mendel Arielle³,van der Heijden Joost W⁴,Simsek Suat¹,Bax Willem A¹,Carette Simon³,Voskuyl Alexandre E²,Pagnoux Christian³,Penne Erik L¹

Affiliation:

1. Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands

2. Department of Rheumatology, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands

3. Vasculitis Clinic, Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto, Canada

4. Department of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands

Funder

Dutch Kidney Foundation

Dutch Vasculitis Foundation, the Northwest Academy

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/58/12/2333/31145149/kez229.pdf

Reference10 articles.

1. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis;Watts;Nephrol Dial Transplant,2015

2. Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies;Houben;Rheumatology,2018

3. Atherosclerosis in ANCA-associated vasculitides;Pagnoux;Ann N Y Acad Sci,2007

4. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis;Yates;Ann Rheum Dis,2016

5. CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides;McGeoch;J Rheumatol,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular risk in ANCA-associated vasculitis: Monocyte phenotyping reveals distinctive signatures between serological subsets;Atherosclerosis;2024-10

2. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

3. Cardiovascular risk in ANCA-associated vasculitis: monocyte phenotyping reveals distinctive signatures between serological subsets;2024-01-20

4. Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic health records;Computers in Biology and Medicine;2024-01

5. Prise en charge des comorbidités cardiovasculaires dans les maladies inflammatoires chroniques et dysimmunitaires;La Revue de Médecine Interne;2023-11